Listen to the article
Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has signed a distribution agreement with United Medical Supplies (UNIMED) LLC, a healthcare distributor under the Mohamed & Obaid Al Mulla Group. The two companies formalised the agreement at the World Health Expo (WHX) 2026.
The partnership extends the distribution of Globalpharma’s UAE-manufactured medicines. UNIMED’s distribution network will support market access for Globalpharma’s portfolio, which includes 25 newly launched products, across pharmacies, hospitals, and healthcare channels.
Basem Al-Barahmeh, General Manager of Globalpharma, and Ahmad Jarrar, General Manager of UNIMED, signed the agreement at the UNIMED stand at the World Health Expo 2026. The partnership supports the UAE’s goals for pharmaceutical self-sufficiency and local manufacturing.
Commenting on the collaboration, Basem Al-Barahmeh, General Manager of Globalpharma, said: “Globalpharma continues to invest in strengthening the UAE’s pharmaceutical manufacturing landscape through an expanding product pipeline and advanced production capabilities. Partnering with UNIMED ensures that our high-quality, locally manufactured medicines reach more patients, more efficiently. This collaboration supports the nation’s long-term objectives of supply resilience, accessibility, and regional leadership in pharmaceutical innovation.”
Globalpharma will maintain R&D and manufacturing operations at its facilities in Dubai Investments Park (DIP) under the agreement. UNIMED will distribute selected new product launches through its logistics operations and network of pharmacies and hospitals for delivery across the UAE.
Ahmad Jarrar, General Manager of UNIMED, said: “Our partnership with Globalpharma represents a powerful alignment between two homegrown entities dedicated to the UAE’s healthcare future. As a member of the Mohamed & Obaid AlMulla Group, UNIMED is deeply committed to supporting the government’s mandate for local manufacturing. By providing a world-class logistical backbone for Globalpharma’s selected products, we are ensuring that ‘Made in the UAE’ pharmaceuticals are synonymous with reliability and accessibility.”
The agreement supports the development of the UAE’s pharmaceutical sector by building industry partnerships, strengthening local value chains, and encouraging collaboration across healthcare.
